Enrolling Studies

Below is the list of studies which are currently open for enrollment to those who qualify.

Study Name Indication Description Location Stipend Apply
MLS-101-202HypertensionA Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of an investigational medication in Subjects with Uncontrolled Hypertension on a Standardized Medication Regimen Springboro, Ohio$500Apply
APEX (PSA3004)Psoriatic ArthritisA Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Subcutaneously Administered Guselkumab in Improving the Signs and Symptoms and Inhibiting Radiographic Progression in Participants with Active Psoriatic Arthritis.Springboro, Ohio$1040Apply
TOPAZ-2Systemic Lupus ErythematosusA Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of a new investigational product in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of CareMiamisburg, Ohio$7224Apply
MyovantProstate Cancer - GeneralA Multi-Center, Prospective, Observational Study of Patients Being Treated with ORGOVYXDayton, OH$120Apply

Upcoming Studies

Here is a list of the studies which we are not currently enrolling but expect to begin soon...

We currently do not have an upcoming studies to report.

How long do studies typically remain open for enrollment?

Studies typically have an enrollment period of about 6-months to a year. Of course, some studies enrollment windows are much shorter or longer depending on the enrollment criteria.

How many patients get enrolled on a study?

Most studies we conduct are multi-center studies, meaning there are many sites enrolling the same study across the country or globally. At STAT Research, we typically have enrollment numbers between 1 to 10 per study.